A Phase I Clinical Trial Assessing the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of NTP42:KVA4, a Novel Thromboxane Receptor Antagonist, in Healthy Subjects

NTP42 - ATXA Therap

B. Kinsella1; H. M. Reid1; E. P. Mulvaney1; M. Boyce2; T. Yamamoto2; M. Maginn1; C. Perkins1

Mar 25, 2023